These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9383841)

  • 21. Ovarian endometrioid adenocarcinoma arising from endometriosis in a young woman.
    Tagashira Y; Shimada M; Kigawa J; Iba T; Terakawa N
    Gynecol Oncol; 2003 Dec; 91(3):643-7. PubMed ID: 14675692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ovarian cancer hormonal and environmental risk effect.
    Vo C; Carney ME
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):687-700, viii. PubMed ID: 18061864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two case reports of ovarian cancer after long-term tamoxifen treatment for breast cancer.
    Ohara N; Kobayashi A
    J Obstet Gynaecol; 2002 Sep; 22(5):572-3. PubMed ID: 12521448
    [No Abstract]   [Full Text] [Related]  

  • 24. Endometrioid borderline ovarian tumor arising from endometriotic cyst: short-term change of sonographic appearance.
    Virgilio BA; Pontrelli G; Fattizzi N; Sacchi D; Basile F; Noventa M; Scioscia M
    Ultrasound Obstet Gynecol; 2020 May; 55(5):692-694. PubMed ID: 31568603
    [No Abstract]   [Full Text] [Related]  

  • 25. Extraluminal bowel obstruction by endometrioid adenocarcinoma 34 years post-hysterectomy: risks of unopposed oestrogen therapy.
    Wang TT; Jabbour RJ; Girling JC; McDonald PJ
    J R Soc Med; 2011 Oct; 104(10):421-3. PubMed ID: 21969480
    [No Abstract]   [Full Text] [Related]  

  • 26. [Association between endometriosis and ovarian cancer].
    Nyhøj L; Mathiesen R; Jochumsen KM
    Ugeskr Laeger; 2010 Nov; 172(48):3336-9. PubMed ID: 21118664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy and risk of epithelial ovarian cancer.
    Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
    Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exacerbation of endometriosis as a result of premenopausal tamoxifen exposure.
    Rose PG; Alvarez B; Maclennan GT
    Am J Obstet Gynecol; 2000 Aug; 183(2):507-8. PubMed ID: 10942499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endometriosis and malignoma].
    Ulrich U; Richter O; Wardelmann E; Valter M; Schmutzler R; Sillem M; Possover M; Mallmann P
    Zentralbl Gynakol; 2003; 125(7-8):239-42. PubMed ID: 14505256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
    Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
    Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian Endometrioid Adenocarcinoma Arising in Endometriosis: A Case Report.
    Nahar K; Ferdous B; Akhter N; Shamsunnahar PA; Khatun K; Begum SA; Aziz MA
    Mymensingh Med J; 2018 Apr; 27(2):420-423. PubMed ID: 29769513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical discussion of the relationship between endometriosis and epithelial ovarian cancer].
    Zhang Y; Huang H; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):544-6. PubMed ID: 11360640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endometriosis and endometriosis-related ovarian neoplasms].
    Totev T; Tomov S; Gorchev G
    Akush Ginekol (Sofiia); 2013; 52(6):38-42. PubMed ID: 24501879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Squamous cell carcinoma of the ovary.
    Tetu B; Silva EG; Gershenson DM
    Arch Pathol Lab Med; 1987 Sep; 111(9):864-6. PubMed ID: 3632305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.
    Cohen I; Figer A; Tepper R; Shapira J; Altaras MM; Yigael D; Beyth Y
    Gynecol Oncol; 1999 Feb; 72(2):202-7. PubMed ID: 10021302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy in women with past history of endometriosis.
    Soliman NF; Hillard TC
    Climacteric; 2006 Oct; 9(5):325-35. PubMed ID: 17000581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ovarian endometriosis].
    Karseladze AI
    Arkh Patol; 1990; 52(9):24-9. PubMed ID: 2270976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?
    Vercellini P; Viganò P; Buggio L; Makieva S; Scarfone G; Cribiù FM; Parazzini F; Somigliana E
    Best Pract Res Clin Obstet Gynaecol; 2018 Aug; 51():151-168. PubMed ID: 29551389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF; Maksimov SIa; Bulgatova EA; Meshkova IE; Chepik OF; Berstein LM
    Vopr Onkol; 2003; 49(2):198-204. PubMed ID: 12785205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement therapy and risk of epithelial ovarian cancer.
    Risch HA
    Gynecol Oncol; 1996 Nov; 63(2):254-7. PubMed ID: 8910636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.